The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPM.L Regulatory News (MPM)

  • There is currently no data for MPM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Adjournment of GM & suspension of trading

21 Oct 2019 07:00

RNS Number : 4628Q
mporium Group PLC
21 October 2019
 

The information communicated in this announcement includes inside information for the purposes of Article 7 Regulation 596/2014.

 

Mporium Group plc

("Mporium", the "Company" or the "Group")

 

Statement re adjournment of GM & suspension of trading

 

Mporium announces that its directors have taken the difficult decision to seek an indefinite adjournment of the Company's forthcoming general meeting (as detailed in the Company's announcement of 30 September 2019) and to request a suspension in the trading of its shares on AIM in view of a critical uncertainty with regard to its financial position.

 

On 25 January 2019, the Company entered into a Strategic Collaboration Agreement with Allay (UK) Ltd ("Allay") pursuant to which the Company was appointed by Allay as the exclusive supplier to Allay of customers and leads for Allay's business in seeking redress for breaches of consumer regulation (particularly, payment protection insurance ("PPI")). As part of this arrangement, Allay paid Mporium for selected leads acquired from the Company's partners and the Company would in turn "pass through" these payments to its partners.

 

The Company understood until recently that the nature of the services provided by Mporium and Allay in these circumstances were exempt for VAT purposes but, following recent discussions with HM Revenue & Customs ("HMRC") and the Company's tax advisers, it is understood that this may not be the case. The Company has received advice that HMRC's position is informed by findings in recent unconnected VAT Tribunal cases that may be subject to further challenge but, as the Company is not a party to these disputes, there can be no certainty that these findings would indirectly favour the Company's position or their timing.

 

HMRC have not to date issued a formal notification to Mporium requiring payment and further submissions to HMRC are planned. The Company estimates that the potential liability, were it to arise, would be in the region of £3.5 million (in respect of transactions totalling approximately £18 million). The Company does not expect that it would have the resources to meet such a liability. In light of this and the associated uncertainty, the Company's directors have concluded that it would not be appropriate to finalise the fundraising described in the announcement of 30 September 2019.

 

As stated in that announcement, this fundraising was needed (amongst other things) to support the Group in meeting its short-term working capital requirements and that further external financial support was also expected to be needed in the next financial year. In the absence of this fundraising, and aside from the uncertainty with regard to the potential VAT liability described above, the directors believe they have no choice but to conclude that there is a fundamental uncertainty regarding the Company's ability to continue as a going concern. The Company is taking specialist advice on the most appropriate course of action in these circumstances.

 

The Company will provide an update as soon as possible.

 

Charles Pendred, chairman of the Company commented: "It is extremely frustrating that this matter has arisen so unexpectedly at a time when the forward vision for the Company looked so promising. The leadership of the Company has changed, the cost base had been substantially reduced, the new strategy with its complementary acquisition was being implemented and current trading was encouraging. The lead generation business with Allay had also ceased. The Board are deeply upset at this outcome and every effort has been, and is being made, to find a solution."

 

 

Enquiries

 

Mporium:

020 3841 8411

Tom Smith, Chief Executive Officer

 

 

 

finnCap (NOMAD / joint broker)

020 7220 0500

Henrik Persson / Anthony Adams (Corporate Finance)

Andrew Burdis (Corporate Broking)

 

 

Novum Securities Limited (joint broker)

020 7399 9427

Colin Rowbury (Corporate Broking)

 

 

 

Yellow Jersey PR:

020 3004 9512

Joseph Burgess

 

 

 

 

About Mporium Group PLC

Mporium is a software company delivering high performance advertising campaigns through its proprietary technology platform, IMPACT. Mporium delivers automation and innovation to the advertising industry and the IMPACT platform enables customers to identify and leverage moments when there are significant changes in the levels of consumer engagement. Advertisers using the platform can optimise their campaigns through event-driven marketing, targeting audiences at the exact moments when consumer interest is at its highest. Further information can be found at www.mporium.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCPGGACUUPBGRU
Date   Source Headline
4th Dec 20196:17 pmRNSStatement re Creditors' Voluntary Liquidation
20th Nov 20196:00 pmRNSMporium Group
20th Nov 20194:43 pmRNSAppointment of Administrator for Mporium Ltd
20th Nov 20193:03 pmRNSResignation of NOMAD
21st Oct 20197:30 amRNSSuspension - Mporium Group PLC
21st Oct 20197:00 amRNSAdjournment of GM & suspension of trading
30th Sep 20197:01 amRNSProposed acquisition and fundraising
30th Sep 20197:00 amRNSHalf-year Results
26th Sep 20192:00 pmRNSPrice Monitoring Extension
19th Sep 20194:29 pmRNSBlock Admission Six Monthly Return
4th Sep 20197:00 amRNSCommercial Partnership with Click Labs Group
28th Aug 20197:00 amRNSCommercial agreement w/ major media agency network
20th Aug 201911:04 amRNSHolding(s) in Company
20th Aug 20197:00 amRNSHolding(s) in Company
20th Aug 20197:00 amRNSHolding(s) in Company
20th Aug 20197:00 amRNSHolding(s) in Company
15th Aug 20199:20 amRNSIssue of Shares, Warrants and Total Voting Rights
12th Aug 201912:02 pmRNSHolding(s) in Company
30th Jul 20197:00 amRNSPCA Dealing
24th Jul 201910:33 amRNSResult of AGM
23rd Jul 20197:00 amRNSDirectorate Changes and Update on Strategy
11th Jul 20197:00 amRNSSale of Fast Web Media
2nd Jul 20195:36 pmRNSResult of GM - Replacement
2nd Jul 20193:30 pmRNSResult of GM
28th Jun 20197:00 amRNSFinal Results
14th Jun 20197:00 amRNSUpdate on Fundraising and Posting of Circular
11th Jun 201911:05 amRNSSecond Price Monitoring Extn
11th Jun 201911:00 amRNSPrice Monitoring Extension
11th Jun 20197:23 amRNSFundraising, Update on FY results & Biz Structure
3rd Jun 20193:00 pmRNSUpdate on Report and Accounts
15th May 20192:59 pmRNSBlock Listing Return
4th Apr 20197:00 amRNSQ1 Update
20th Mar 20197:00 amRNSContract extension for MporiumX
13th Mar 20192:34 pmRNSHolding(s) in Company
13th Mar 20197:00 amRNSNew agreement for IMPACT
20th Feb 20198:20 amRNSHolding(s) in Company
18th Feb 201912:14 pmRNSHolding(s) in Company
15th Feb 20191:47 pmRNSHolding(s) in Company
15th Feb 201910:39 amRNSHolding(s) in Company
15th Feb 201910:35 amRNSHolding(s) in Company
15th Feb 201910:32 amRNSHolding(s) in Company
15th Feb 201910:25 amRNSHolding(s) in Company
12th Feb 20194:40 pmRNSSecond Price Monitoring Extn
12th Feb 20194:35 pmRNSPrice Monitoring Extension
12th Feb 20197:00 amRNSUpdate on Revenue and the Allay Agreement
11th Feb 201910:04 amRNSResult of General Meeting
8th Feb 20197:00 amRNSNew Agreement for MporiumX
30th Jan 20194:40 pmRNSSecond Price Monitoring Extn
30th Jan 20194:35 pmRNSPrice Monitoring Extension
25th Jan 20197:00 amRNSStrategic Collaboration Agreement & Notice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.